Activating Compound | Comment | Organism | Structure |
---|---|---|---|
efavirenz | EFV, activates the enzyme pharmacologically as a potential target for Alzheimers disease | Homo sapiens | |
additional information | pharmaceuticals activate CYP46A1 allosterically through binding to the site on the cytosolic protein surface, which is different from the enzyme active site facing the membrane | Homo sapiens |
Application | Comment | Organism |
---|---|---|
medicine | the enzyme is a potential target for Alzheimers disease as it can be activated pharmacologically by some of the marketed drugs as exemplified by efavirenz (EFV), the anti-HIV medication | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
gene CYP46A1, recombinant expression of wild-type full-length and mutant truncated forms of enzyme CYP46A1 in Escherichia coli | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
analysis of the crystal structure of cholesterol sulfate-bound CYP46A1, PDB ID 2Q9F | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
K422A | site-directed mutagenesis, the K422A mutant retains the ability to be activated by EFV, although to a slightly lower extent than wild-type CYP46A1. The cholesterol-bound K422A mutant also shows cooperativity similar to cholesterol-bound wild-type CYP46A1. Binding to NADPH cytochrome P450 oxidoreductase is reduced compared to the wild-type | Homo sapiens |
K94A | site-directed mutagenesis, the K94A replacement produces inactive P420 protein | Homo sapiens |
additional information | construction of truncated enzyme mutant DELTA(3-27)CYP46A1 | Homo sapiens |
R138A | site-directed mutagenesis, binding to NADPH cytochrome P450 oxidoreductase is reduced compared to the wild-type | Homo sapiens |
R139A | site-directed mutagenesis, binding to NADPH cytochrome P450 oxidoreductase is reduced compared to the wild-type | Homo sapiens |
R147A | site-directed mutagenesis, binding to NADPH cytochrome P450 oxidoreductase is unaltered compared to the wild-type | Homo sapiens |
R424A | site-directed mutagenesis, the R424A mutant shows a total loss of the ability to be activated by EFV. The R424A replacement affects EFV binding to the allosteric site and cholesterol binding to the CYP46A1 active site. Binding to NADPH cytochrome P450 oxidoreductase is reduced compared to the wild-type | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | Michaelis-Menten kinetics | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
microsome | - |
Homo sapiens | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
cholesterol + [reduced NADPH-hemoprotein reductase] + O2 | Homo sapiens | - |
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9Y6A2 | gene CYP46A1 | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
cholesterol + [reduced NADPH-hemoprotein reductase] + O2 | - |
Homo sapiens | (24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
additional information | coupled assay with recombinant Rattus norvegicus NADPH cytochrome P450 oxidoreductase | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cholesterol hydroxylase | - |
Homo sapiens |
CYP46A1 | - |
Homo sapiens |
cytochrome P450 46A1 | - |
Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.2 | - |
assay at | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
heme | - |
Homo sapiens | |
NADPH | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
additional information | mapping of the binding region for CYP46A1 redox partner oxidoreductase and identification of allosteric and redox partner binding sites which share a common border, by using a combination of hydrogen-deuterium exchange coupled to mass spectrometry, computational modeling, site-directed mutagenesis, and analysis of the CYP46A1 crystal structure, overview. Residues K422 and R424 are important for enzyme activity | Homo sapiens |
physiological function | cholesterol 24-hydroxylase controls cholesterol elimination from the brain | Homo sapiens |
physiological function | mechanism of CYP46A1 allostery and the pathway for the signal transmission from the P450 allosteric site to the active site, overview | Homo sapiens |